This inventor holds 1 USPTO granted patent. Top assignee: The Hong Kong University of Science and Technology. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations of Xuewen He in Bioconjugate Technology
Introduction
Xuewen He is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of bioconjugate technology, particularly through his innovative research and patent work. His expertise lies in the development of aggregation-induced emission-bacteriophage bioconjugates, which have potential applications in pharmaceuticals and diagnostics.
Latest Patents
Xuewen He holds a patent for "Aggregation induced emission-bacteriophage bioconjugates." This patent describes a novel bioconjugate that includes a bacteriophage covalently bonded to at least one aggregation-induced emission luminogen via an optional linker. The patent also covers pharmaceutical compositions that include these bioconjugates, as well as methods for their preparation and use. He has 1 patent to his name, showcasing his innovative approach to bioconjugate technology.
Career Highlights
Xuewen He is affiliated with The Hong Kong University of Science and Technology, where he conducts research and teaches. His work has garnered attention in the scientific community, and he is recognized for his contributions to the advancement of bioconjugate applications in various fields.
Collaborations
Xuewen He collaborates with Benzhong Tang, a fellow researcher, to further explore the potential of bioconjugate technologies. Their partnership enhances the research output and innovation in their respective fields.
Conclusion
Xuewen He is a notable inventor whose work in aggregation-induced emission-bacteriophage bioconjugates represents a significant advancement in bioconjugate technology. His contributions to the field are expected to have lasting impacts on pharmaceutical applications and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile